ANT2–ATP Synthasome: Powering the Mitochondrial Engine of Breast Cancer Progression

Presenter: Dr. Chia-Jung Li, Kaohsiung Veterans General Hospital, Taiwan

Presentation Type: Poster (In-Person)


Title:
Functional Integration of the ATP Synthasome Drives Mitochondrial Efficiency in Breast Carcinoma


πŸ” Overview

Breast cancer cells possess an extraordinary ability to adapt their energy metabolism, supporting aggressive growth and metastasis. Dr. Chia-Jung Li’s latest research dives into the mitochondrial mechanisms behind this transformation — focusing on the adenine nucleotide translocase 2 (ANT2) protein and its association with the ATP synthasome complex.

The study provides new evidence showing how functional integration between ANT2 and ATP5B boosts mitochondrial efficiency, powering the metastatic potential of breast cancer cells.


🌟 Key Research Highlights

·         ANT2 Overexpression in Aggressive Tumors:
Elevated ANT2 levels were linked to poor survival outcomes and increased metastatic activity in breast cancer tissues.

·         Functional Role in Energy Production:
ANT2 knockdown significantly reduced ATP generation, OXPHOS activity, and cell invasion, revealing its central role in tumor metabolism.

·         Therapeutic Discovery – Cymarin:
Through pharmacogenomic screening, cymarin emerged as a potent ANT2 inhibitor, effectively reducing tumor growth and metastasis in preclinical models.

·         Mitochondrial Network Insights:
ANT2 was found to interact with ATP5B, forming a powerful ATP synthasome that enhances energy flux in invasive cancer cells.

·         Clinical Implications:
Targeting ANT2 could be a breakthrough strategy to disrupt mitochondrial energy flow, limiting cancer progression and improving patient outcomes.


πŸ‘¨πŸ”¬ About the Researcher

Dr. Chia-Jung Li is a distinguished mitochondrial biologist and cancer researcher from Taiwan, renowned for his work on mitochondrial dysfunction, cellular metabolism, and aging-related diseases. With over 130 SCI-indexed publications, his research bridges fundamental biochemistry with translational oncology — driving new directions in mitochondria-targeted therapies.



🌐 Conference Information

πŸ“ Event: International Conference on Cancer Science and Research
πŸ“… Dates: November 17–19, 2025
πŸ›Venue: Singapore & Online (Hybrid)
πŸ”— Event Website
πŸ“§ Email: cancer@mathewsconference.com
πŸ“ž Phone: +1 (312) 462-4448
πŸ’¬ WhatsApp: +1 (424) 377 0967
🐦 X (Twitter): @CancerWorldConf
πŸ“ Submit Abstract | Register Now


#ANT2 #BreastCancerResearch #MitochondrialFunction #CancerMetabolism #ATP #OXPHOS #CancerTherapy #Mitochondria #Cymarin #Metastasis #OncologyConference #CancerScience2025 #SingaporeConference #CancerResearchInnovation